Rx&D bestows health research and innovation awards

Dr. Brett Finlay, a professor in the Departments of Biochemistry and Molecular Biology, and Microbiology and Immunology at The University of British Columbia (UBC), has been awarded the 2014 Prix Galien Canada Research Award.

The Prix Galien recognizes outstanding contributions in the field of Canadian pharmaceutical research and innovation. Dr. Finlay was recognized for his contributions to microbiology, pharmacology, vaccine development, human and animal disease pathogenesis, and for transforming our understanding of bacterial interaction with the host cell.

The award was announced at the Rx&D Health Research Foundation awards ceremony in Toronto, ON, on November 19, 2014.

In August 2014, Dr. Finlay and Dr. Kelly McNagny, an AllerGen investigator and a professor in the Department of Medical Genetics at UBC, published findings that antibiotic use in early life alters gut bacteria and enhances future susceptibility to inflammatory lung disease.